AIS Healthcare is a prominent healthcare provider recognized as a revolutionary force in targeted drug delivery and advanced infusion care sectors. The organization maintains a patient-centric approach and combines top-notch technology and unmatched medical expertise to offer innovative healthcare solutions. Read on for more information about this revolutionary firm that has positively impacted the healthcare industry.
Founding and the Executive Team
AIS (Advanced Infusion Solutions) was founded in 1998 by Charles (Chuck) R. Bell, Jr., a renowned healthcare industry veteran who began his home infusion career in 1992. The company has grown tremendously by offering innovative healthcare solutions. The executive team comprises experienced professionals in medical research, technology, clinical processes, and business management. Chuck Bell is the president, and Simon Castellanos holds the Chief executive officer position.
Advanced Infusion Solutions (AIS) Healthcare Offerings
AIS exceeds expectations by offering patients and their caregivers exactly what they need to thrive. With impressive innovations in targeted drug delivery and infusion care, the company is always striving to advance quality and improve the lives of all its patients.
AIS Healthcare has two 503A specialty compounding pharmacies that make and distribute quality and sterile prescriptions nationwide. They also have highly skilled nurses who offer support and in-home care services to patients for as long as needed.
AIS Health Service Accreditations and Subsidiaries
Advanced Infusion Solutions Healthcare is fully accredited by the Accreditation Commission for Health Care and URAC, making it a safer option than other pharmacies and infusion care providers.
AIS continues to increase its reach and impact through strategic acquisitions and mergers with complementary healthcare providers. These subsidiaries include specialized clinics, research centers, and pharmacies that embrace targeted drug delivery and advanced infusion care.
AIS Healthcare Divisions
Targeted Drug Delivery
AIS health service provider specializes in targeted drug delivery (TDD), an innovative approach that accurately administers prescriptions directly to the affected organ or tissue. TDD reduces the side effects of medications, promotes a patient’s comfort, and increases therapeutic effectiveness.
The organization has two high-tech 503A specialty compounding pharmacies that manufacture and deliver over 140,000 quality and patient-specific prescriptions annually.
Advanced Infusion Care
The second division focuses on offering advanced infusion therapy treatments such as intravenous (IV) and subcutaneous (SubQ) immunoglobulin therapy patient care. AIS collaborates with physicians and licensed home infusion experts to provide consistent and patient-specific in-home infusion services nationwide.